Glanzmann Thrombasthenia (GT)
Gene or Region: ITGA2B
Reference Variant: G, 10bp indel (GACAGGTGAG)
Mutant Variant: C, - (deletion)
Affected Breeds: Thoroughbred, Standardbred, Oldenburg, Peruvian Paso, American Paint Horse, Appaloosa and American Quarter Horse
Research Confidence: Discovery - Findings require expanded validation
Explanation of Results: GT/GT = homozygous for Glanzmann Thrombasthenia, trait expressed GT/n = heterozygous for Glanzmann Thrombasthenia, trait possibly expressed n/n = no variant detected
General Description for Glanzmann Thrombasthenia (GT)
Glanzmann Thrombasthenia (GT) is an inherited platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings. Two mutations in the gene encoding platelet glycoprotein IIb, Integrin Alpha-2B (ITGA2B), have been implicated in the GT condition. Although GT has been associated with a recessive mode of inheritance, heterozygous combinations from both variants have been implicated in GT cases. GT can be a differential diagnosis for horses with platelet-type bleeding, especially nasal bleeding not related to exercise or of unknown origin (not thrombocytopenic or from von Willebrand disease).
Genotype
G/G and/or GACAGGTGAG/GACAGGTGAG: No variants - Negative for the known genetic factors of Glanzmann Thrombasthenia (GT). Horse may still have Glanzmann Thrombasthenia (GT) signs from novel/unknown mutations.
G/C or GACAGGTGAG: One allele (at either locus) - Horse is a carrier for Glanzmann Thrombasthenia (GT). Selective breeding is advised as to not produce homozygous or compound heterozygous offspring.
G/C and GACAGGTGAG/- ; or C/C ; or -/-: Two alleles (at either locus) - Horse is affected by Glanzmann Thrombasthenia (GT). Please consult with your attending veterinarian about management for this condition.
References
Christopherson, P.W., van Santen, V.L., Livesey, L. and Boudreaux, M.K. (2007), A 10-Base-Pair Deletion in the Gene Encoding Platelet Glycoprotein IIb Associated with Glanzmann Thrombasthenia in a Horse. Journal of Veterinary Internal Medicine, 21: 196-198. https://doi.org/10.1111/j.1939-1676.2007.tb02947.x
Christopherson PW, Insalaco TA, Santen VL van, Livesey L, Bourne C, Boudreaux MK. Characterization of the cDNA Encoding αIIb and β3 in Normal Horses and Two Horses with Glanzmann Thrombasthenia. Veterinary Pathology. 2006;43(1):78-82. doi:10.1354/vp.43-1-78
More Horse Health
"Warmblood" Fragile Foal Syndrome
"Warmblood" fragile foal syndrome (FFS) is a connective tissue disorder resulting in joint laxity and extremely thin skin that is only loosely connected to the body. The skin is easily torn, resulting in lacerations, hematomas, and seromas across the foal. Affected foals are euthanized shortly after birth.
Androgen Insensitivity Syndrome
Androgen Insensitivity Syndrome (AIS) is an X-linked disorder of sexual development resulting in a female horse with XY chromosomes. Horses with AIS exhibit stallion-like behavior such as agression toward other horses, Flehman response and vocalization toward cycling mares.
Cerebellar Abiotrophy
Cerebellar Abiotrophy (CA) is a degenerative neurological disorder, due to the death of neurons in the brain. Symptoms (head tremors, lack of coordination, wide stances, exaggerated gain, difficulty rising and startling easily), typically appear in foals between six weeks and four months of age.
Chronic Idiopathic Anhidrosis Risk
Chronic Idiopathic Anhidrosis Risk (CIA) is the inability to sweat in response to increased body temperature, (AKA "non-sweater"). This condition is dangerous and sometimes life-threatening for horses, who rely on sweating for 65-70% of their temperature regulation.